Coronavirus disease (COVID-19) and Intellectual Property: Patents

I'm including this patent because the inventor, Jacob E. Glanville, has hinted that he is using this patent to develop a potential treatment for COVID-19. The invention described in this patent has already been used for treatment of Ebola.

Respirator patents, which are complex and CURRENTLY NOT IN PATENT POOLS, are critical to the COVID-19 pandemic.

This patent application closely relates to Dr. Jacob Glanville's antibody-manipulation strategy to treat COVID-19

Biocatalysts are the cornerstone of biosensors that are key for preserving a pleasant civilization while managing a pandemic.

This patent expired in 2017, but it has played an influential role in biosensor development

This patent expired in 2016, but it played a significant role in biosensor development continuing today for the pandemic response

This is a 2015 patent that is widely used now for making COVID biosensors and could become a Standards Essential Patent for pandemic response protocol

This is a PCT application, not one that has been currently granted. I include it because it is administratively relevant for the granting of patents pertaining to COVID-19 vaccines.

A Chinese patent for a coronavirus vaccine from 2018

This is an application, not a patent.

Application

This recently republished patent from 2015 has been used in the development of a COVID-19 vaccine and treatment

This patent, although long expired, has proven critical to helping people make a vital COVID-19 treatment because of the enablement of the claims, which tell chemists how to make this drug.

This invention pertains to the manufacture of convalescent plasma, a treatment for COVID-19

This patent describes a very important invention for convalescent plasma manufacturing, and it has played an important role. Because of the patent's role in securing DoD grants, there is reason to consider the possibility of other patents related to this patent under secrecy order.

Assignee: Plasma Technologies, LLC

Extremely relevant to convalescent plasma treatments for COVID-19

Relevant to dexamethasone treatment

A potential COVID-19 treatment

AR-12 is a potential COVID-19 treatment

The BioNTech vaccine, developed with Pfizer, is a revolutionary kind of vaccine that has emerged as a potential candidate for COVID-19 treatment. Even though most physicians and other scientific experts consider the Moderna, Johnson and Johnson, and AstraZeneca vaccines to be more helpful for this particular pandemic, the kind of technology used is important to highlight here.